GW & Wade’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $964K | Buy |
11,903
+13
| +0.1% | +$1.01K | 0.03% | 229 |
|
|
2023
Q3 | $891K | Buy |
11,890
+242
| +2% | +$18.6K | 0.03% | 225 |
|
|
2023
Q2 | $898K | Sell |
11,648
-129
| -1% | -$10.3K | 0.03% | 218 |
|
|
2023
Q1 | $977K | Sell |
11,777
-636
| -5% | -$52.7K | 0.04% | 207 |
|
|
2022
Q4 | $1.07M | Buy |
12,413
+12
| +0.1% | +$950 | 0.04% | 190 |
|
|
2022
Q3 | $765K | Buy |
12,401
+25
| +0.2% | +$1.58K | 0.04% | 194 |
|
|
2022
Q2 | $765K | Buy |
12,376
+374
| +3% | +$23.2K | 0.03% | 209 |
|
|
2022
Q1 | $714K | Sell |
12,002
-3,582
| -23% | -$229K | 0.03% | 213 |
|
|
2021
Q4 | $1.13M | Buy |
15,584
+354
| +2% | +$24.4K | 0.05% | 183 |
|
|
2021
Q3 | $1.06M | Sell |
15,230
-706
| -4% | -$49.6K | 0.05% | 182 |
|
|
2021
Q2 | $1.1M | Sell |
15,936
-3,585
| -18% | -$239K | 0.05% | 176 |
|
|
2021
Q1 | $1.26M | Buy |
19,521
+3,977
| +26% | +$256K | 0.07% | 148 |
|
|
2020
Q4 | $906K | Sell |
15,544
-545
| -3% | -$32.9K | 0.06% | 146 |
|
|
2020
Q3 | $1.02M | Buy |
16,089
+16
| +0.1% | +$1.11K | 0.08% | 116 |
|
|
2020
Q2 | $1.24M | Buy |
16,073
+10,403
| +183% | +$797K | 0.1% | 104 |
|
|
2020
Q1 | $424K | Sell |
5,670
-3,143
| -36% | -$217K | 0.04% | 143 |
|
|
2019
Q4 | $573K | Buy |
8,813
+334
| +4% | +$21.8K | 0.04% | 147 |
|
|
2019
Q3 | $537K | Sell |
8,479
-11
| -0.1% | -$719 | 0.05% | 146 |
|
|
2019
Q2 | $574K | Sell |
8,490
-85
| -1% | -$5.59K | 0.05% | 140 |
|
|
2019
Q1 | $557K | Buy |
8,575
+116
| +1% | +$7.71K | 0.05% | 141 |
|
|
2018
Q4 | $529K | Sell |
8,459
-920
| -10% | -$64.3K | 0.06% | 135 |
|
|
2018
Q3 | $724K | Buy |
9,379
+19
| +0.2% | +$1.44K | 0.08% | 128 |
|
|
2018
Q2 | $663K | Sell |
9,360
-657
| -7% | -$46.4K | 0.07% | 131 |
|
|
2018
Q1 | $755K | Buy |
10,017
+324
| +3% | +$25.8K | 0.09% | 122 |
|
|
2017
Q4 | $694K | Buy |
9,693
+48
| +0.5% | +$3.65K | 0.08% | 123 |
|
|
2017
Q3 | $781K | Buy |
9,645
+6
| +0.1% | +$459 | 0.09% | 113 |
|
|
2017
Q2 | $682K | Buy |
9,639
+15
| +0.2% | +$998 | 0.09% | 115 |
|
|
2017
Q1 | $654K | Sell |
9,624
-2,556
| -21% | -$180K | 0.09% | 115 |
|
|
2016
Q4 | $872K | Sell |
12,180
-1,355
| -10% | -$101K | 0.14% | 95 |
|
|
2016
Q3 | $1.07M | Buy |
13,535
+110
| +0.8% | +$8.94K | 0.19% | 89 |
|
|
2016
Q2 | $1.12M | Sell |
13,425
-221
| -2% | -$19.6K | 0.19% | 98 |
|
|
2016
Q1 | $1.25M | Buy |
13,646
+364
| +3% | +$32.8K | 0.24% | 73 |
|
|
2015
Q4 | $1.34M | Buy |
13,282
+286
| +2% | +$29.8K | 0.28% | 69 |
|
|
2015
Q3 | $1.28M | Sell |
12,996
-341
| -3% | -$37.9K | 0.28% | 74 |
|
|
2015
Q2 | $1.56M | Sell |
13,337
-618
| -4% | -$67.5K | 0.31% | 72 |
|
|
2015
Q1 | $1.37M | Buy |
13,955
+9,155
| +191% | +$930K | 0.26% | 78 |
|
|
2014
Q4 | $452K | Buy |
+4,800
| New | +$496K | 0.12% | 89 |
|
Other funds holding GILD
GW & Wade's GILD Position: Q4 2023 in Review
GW & Wade increased its Gilead Sciences (GILD) stake by 0.11% in Q4 2023, buying an estimated $1.01K and bringing the position to 11,903 shares worth $964K. The position accounts for 0.03% of the portfolio, ranked #229.
GW & Wade first reported a position in GILD in Q4 2014 and has held it in 37 quarters since. The position peaked at $1.56M in Q2 2015. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- GW & Wade held 11,903 shares of Gilead Sciences worth $964K as of Q4 2023.
- GW & Wade bought 13 Gilead Sciences shares in Q4 2023, an estimated $1.01K.
- Gilead Sciences made up 0.03% of GW & Wade's portfolio in Q4 2023, its #229 holding.
- GW & Wade first reported a position in Gilead Sciences in Q4 2014 and has held it in 37 quarters since.
- GW & Wade's Gilead Sciences position peaked at $1.56M in Q2 2015.
- 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.